Return On Assets in % of Cue Biopharma, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cue Biopharma, Inc. quarterly/annual Return On Assets history and change rate from Q3 2018 to Q3 2025.
  • Cue Biopharma, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -119 %, a 35% decline year-over-year.
  • Cue Biopharma, Inc. annual Return On Assets for 2024 was -93.9 %, a 32% decline from 2023.
  • Cue Biopharma, Inc. annual Return On Assets for 2023 was -71.1 %, a 15.1% decline from 2022.
  • Cue Biopharma, Inc. annual Return On Assets for 2022 was -61.8 %, a 19.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Cue Biopharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -119 -30.8 -35% 01 Jul 2025 30 Sep 2025
Q2 2025 -111 -28.3 -34.2% 01 Apr 2025 30 Jun 2025
Q1 2025 -115 -37 -47.7% 01 Jan 2025 31 Mar 2025
Q4 2024 -93.9 -22.8 -32% 01 Oct 2024 31 Dec 2024
Q3 2024 -88.1 -22.2 -33.7% 01 Jul 2024 30 Sep 2024
Q2 2024 -82.9 -18.5 -28.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -77.6 -15.5 -25% 01 Jan 2024 31 Mar 2024
Q4 2023 -71.1 -9.33 -15.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -65.9 -10 -18% 01 Jul 2023 30 Sep 2023
Q2 2023 -64.3 -6.47 -11.2% 01 Apr 2023 30 Jun 2023
Q1 2023 -62.1 -8.51 -15.9% 01 Jan 2023 31 Mar 2023
Q4 2022 -61.8 -9.96 -19.2% 01 Oct 2022 31 Dec 2022
Q3 2022 -55.9 -3.3 -6.28% 01 Jul 2022 30 Sep 2022
Q2 2022 -57.9 -12.2 -26.6% 01 Apr 2022 30 Jun 2022
Q1 2022 -53.6 -8.7 -19.4% 01 Jan 2022 31 Mar 2022
Q4 2021 -51.9 -3.19 -6.56% 01 Oct 2021 31 Dec 2021
Q3 2021 -52.6 -2.47 -4.93% 01 Jul 2021 30 Sep 2021
Q2 2021 -45.7 +11.1 +19.5% 01 Apr 2021 30 Jun 2021
Q1 2021 -44.9 +24.9 +35.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -48.7 +23.4 +32.5% 01 Oct 2020 31 Dec 2020
Q3 2020 -50.1 +38.6 +43.5% 01 Jul 2020 30 Sep 2020
Q2 2020 -56.8 +44.9 +44.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -69.8 +21 +23.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -72 +5 +6.49% 01 Oct 2019 31 Dec 2019
Q3 2019 -88.7 -21.2 -31.4% 01 Jul 2019 30 Sep 2019
Q2 2019 -102 01 Apr 2019 30 Jun 2019
Q1 2019 -90.8 01 Jan 2019 31 Mar 2019
Q4 2018 -77 01 Oct 2018 31 Dec 2018
Q3 2018 -67.5 01 Jul 2018 30 Sep 2018

Cue Biopharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -93.9 -22.8 -32% 01 Jan 2024 31 Dec 2024
2023 -71.1 -9.33 -15.1% 01 Jan 2023 31 Dec 2023
2022 -61.8 -9.96 -19.2% 01 Jan 2022 31 Dec 2022
2021 -51.9 -3.19 -6.56% 01 Jan 2021 31 Dec 2021
2020 -48.7 +23.4 +32.5% 01 Jan 2020 31 Dec 2020
2019 -72 +5 +6.49% 01 Jan 2019 31 Dec 2019
2018 -77 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.